v3.22.2.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Total net revenues $ 33,511 $ 31,456 $ 87,096 $ 92,104
Costs and expenses:        
Cost of sales 11,005 13,303 25,772 36,589
Research and development 1,383 1,931 4,602 9,054
Selling, general and administrative 22,997 29,623 80,002 95,959
Amortization of intangible assets 7,691 7,691 23,073 23,073
Change in fair value of derivative liability   (288) (37) (868)
Changes in fair value of acquired contingent consideration (4,576) 2,205 (10,709) (4,224)
Total operating expenses 38,500 54,465 122,703 159,583
Operating loss (4,989) (23,009) (35,607) (67,479)
Other income (expense), net:        
Interest and amortization of debt discount expense (7,465) (7,167) (22,501) (22,697)
Interest income 17 1 38 4
Other income (expense)     1,250 1
Realized loss on foreign currency transactions (1) (1) (1) (4)
Total other expense, net (7,449) (7,167) (21,214) (22,696)
Loss before taxes (12,438) (30,176) (56,821) (90,175)
(Provision for) benefit from income taxes (1,416) 3,105 (28,237) 6,788
Net loss $ (13,854) $ (27,071) $ (85,058) $ (83,387)
Net loss per share—basic $ (0.57) $ (2.43) $ (4.69) $ (8.17)
Net loss per share—diluted $ (0.57) $ (2.43) $ (4.69) $ (8.17)
Weighted average common shares outstanding used in computing net loss per share—basic 24,290 11,131 18,148 10,204
Weighted average common shares outstanding used in computing net loss per share—diluted 24,290 11,131 18,148 10,204
Net Product Revenues        
Revenues:        
Total net revenues $ 29,964 $ 27,851 $ 76,023 $ 81,297
Royalty Revenues        
Revenues:        
Total net revenues 3,047 $ 3,605 10,573 $ 10,807
License Revenue        
Revenues:        
Total net revenues $ 500   $ 500